Porphyria Treatment Market: Introduction
- Porphyria is a group of disorders in which the substance called porphyrin accumulates in the body and affects the nervous system or skin and may cause abdominal pain. Porphyrin is an essential substance for the function of hemoglobin. Porphyria is categorized into two types: acute porphyrias and cutaneous porphyrias. Symptoms of acute porphyrias include severe abdominal pain, constipation or diarrhea, breathing problems, high blood pressure, and seizures. Emergence of innovative therapies is a key factor that is likely to boost the market.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79991
Key Drivers and Opportunities of Global Porphyria Treatment Market
- Surge in number of people with porphyria is anticipated to drive the market. The prevalence of disease is not known; however, it probably ranges from 1 in 500 to 1 in 50,000 people worldwide. Acute porphyrias is a highly common form of diseases in most countries across the globe. It may occur more frequently in countries in Northern Europe such as the U.K. and Sweden.
- Increase in focus on development of better treatment options is anticipated to drive the market. Thus, key players are engaged in the development of new products through research and development. For instance, drug hydroxychloroquine is in phase II clinical trial phase for porphyria cutanea tarda indication.
- Government initiatives and funding to support and expand research & development activities are also likely to augment the market. Furthermore, adoption of rapidly developing innovations further propels the market.
- Governments in developing countries are making significant investments toward modernization of healthcare infrastructure, which is likely to increase access to healthcare. This is expected to increase the demand for advance technologies and thereby creates significant opportunity in the market. Moreover, increase in R&D expenditure leads to development of promising pipeline that caters to significant opportunity in the market
Request for Analysis of COVID-19 Impact on Porphyria Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79991
North America to Capture Major Share of Global Porphyria Treatment Market
- North America is expected to account for a major share of the global porphyria treatment market due to high prevalence of diseases among the population. Moreover, presence of key market players and adoption of advanced healthcare technologies are likely to augment the market in the region.
- The porphyria treatment market in Asia Pacific is projected to expand at a rapid pace during the forecast period owing to a rise in awareness and large patient population. Moreover, government initiatives to improve healthcare infrastructure is likely to propel the market.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79991
Key Players Operating in Global Porphyria Treatment Market
The global porphyria treatment market is highly concentrated due to the presence of key players. A large number of manufacturers hold a major share in their respective regions. Demand for porphyria treatment products has increased in emerging as well as developed markets owing to a surge in number of people with porphyria. Introduction of new products and growth strategies adopted by leading players are likely to drive the global market. For instance, in November 2019, Alnylam Pharmaceuticals, Inc. received approval from U.S. Food and Drug Administration for GIVLAARI (givosiran) injection for subcutaneous use for the treatment of adults with acute hepatic porphyria (AHP).
Major players operating in the global porphyria treatment market are:
- Alnylam Pharmaceuticals, Inc.
- Recordati Rare Diseases Inc.
- Other Prominent Players
Pre Book Porphyria Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=79991<ype=S
Read more information here:
https://www.transparencymarketresearch.com/porphyria-treatment-market.html
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Europe
- Latin America
- The Middle East and Africa
Browse More Trending Reports by Transparency Market Research:
Over the Counter (OTC) Test Market: https://www.transparencymarketresearch.com/over-the-counter-otc-test-market.html
Alport Syndrome Market: https://www.transparencymarketresearch.com/alport-syndrome-market.html
Female Infertility Drugs Market: https://www.transparencymarketresearch.com/female-infertility-drugs-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
